跳至主要内容
临床试验/NCT04849143
NCT04849143Unknown不适用

The Effectiveness of Stingless Bee Honey (Kelulut Honey) Dressing Versus Conventional Gel Dressing for Wound Bed Preparation in Diabetic Patients With Cavity Wounds: A Randomised Controlled Trial

Universiti Sains Malaysia2 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2021年9月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
76
试验地点
2
主要终点
Size of granulation tissue

研究概览

简要总结

There has been no study yet on the effect of stingless bee honey (Kelulut honey) produced by Melipolini sp. in diabetic wound healing in Malaysia. Kelulut honey, apart from possessing similar pro-healing properties with other honey, is also found to have a better antioxidant capacity, anti-inflammatory, and free radical scavenging activity than Tualang honey. These effects are due to the much higher content of phenolic and flavonoid substances in Kelulut honey, the key bioactive factors promoting wound healing and preventing oxidative stress-related injury. Australian researchers have also recently discovered a novel source of the rare disaccharide trehalose in stingless bee's honey, which is highly anti-diabetic and antioxidating. This study aims to investigate the efficacy of honey against gel dressing for wound bed preparation among diabetic patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female
  • Aged between 18-70 years old
  • Patient with full thickness cavity wound
  • Controlled diabetes mellitus (defined as: fasting blood glucose (FBG) < 10 mmol/L upon selection)

排除标准

  • Severely contaminated wound/infected
  • Patient with history of allergy to honey or stingless bee product
  • Patients who are immunocompromised or on chronic steroid use ( defined as use of steroid for more than 2 weeks)
  • Pregnancy
  • End stage renal failure (ESRF) patient

结局指标

主要结局

Size of granulation tissue

时间窗: 30 days

This will be calculated based on the surface area of granulation tissue traced and marked on the Opsite Flexigrid by indelible fine tip marker. The amount of small squares will calculated and this will represent the surface area. The change between baseline and at day 30 will be recorded as percentage.

Wound size reduction

时间窗: 30 days

This will be calculated based on the surface area of the whole wound traced and marked on the Opsite Flexigrid by indelible fine tip marker. The amount of small squares will calculated and this will represent the surface area. The change between baseline and at day 30 will be recorded as percentage.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamad Aizat Bin Rosli

Principal Investigator

Universiti Sains Malaysia

研究点 (2)

Loading locations...

相似试验